Profound Medical (PROF) Q3 2024 Earnings
PROF·Reported November 7, 2024·After market close
Profound Medical reported Q3 2024 revenue of $3.8M, missed analyst consensus of $5.9M by $2.1M. Diluted EPS came in at $-0.38, missed the $-0.30 consensus by $0.08.
Revenue
$3.8Mmissed by $2.1M
Consensus: $5.9MDiluted EPS
$-0.38missed by $0.08
Consensus: $-0.30
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q3 2024 Earnings FAQ
Common questions about Profound Medical's Q3 2024 earnings report.
Profound Medical (PROF) reported Q3 2024 earnings on November 7, 2024 after market close.
Profound Medical reported revenue of $3.8M and diluted EPS of $-0.38 for Q3 2024.
Revenue missed the consensus estimate of $5.9M by $2.1M. EPS missed the consensus estimate of $-0.30 by $0.08.